The document discusses opportunities for cooperation and partnership in biotechnology between India and other countries. It notes that the Indian biotech industry has grown significantly in recent years but still has room for growth. Key opportunities for partnerships include contract research, manufacturing of biogenerics, clinical trials, and bioinformatics. The document outlines India's strengths in these areas like a skilled workforce, low costs, and bio-resources that make it an attractive partner for global biotech companies.
Introduction to Biotechnology in India-History and Evolution. Brief Discussion about Current scenario and scope of Biotechnology in India and top companies.
Patents and Biotechnology- A Presentation by Dr. Kalyan Kankanala - BananaIPBananaIP Counsels
Patents and Biotechnology- A Presentation by Dr. Kalyan Kankanala - BananaIP
BananaIP Counsels, formerly Brain League IP Services, founded in 2004 at the Indian Institute of Management (IIM) Bangalore’s incubation center (NSRCEL), is recognized as an IP/Patent trailblazer in India. The firm’s mission is to help clients maximize business value from their Intellectual Property (IP)/Patents, and gain competitive advantage in the market place. In its evolution from Brain League, BananaIP carries forward the firm’s core values – Merger of Technology,Management and Law, Swift Adaptation to changes in competitive environment, and business driven approach to Intellectual Property (IP)/Patent Services.
Contact Us for Intellectual Property Services
BananaIP Counsels
Regd Office
No.40,3rd Main Road,JC Industrial Estate,
Kanakapura Road,Bangalore – 560 062.
Email: contact@bananaip.com
Telephone: +91-80-26860414 /24/34
Brief Profiles of 50 Bio-entrepreneurs of India along with their company information. Biotechnology in India is in nascent stage. India has around 800 biotech companies out of which only 50 are presented here. They represent all the waves of biotech growth in India.
Introduction to Biotechnology in India-History and Evolution. Brief Discussion about Current scenario and scope of Biotechnology in India and top companies.
Patents and Biotechnology- A Presentation by Dr. Kalyan Kankanala - BananaIPBananaIP Counsels
Patents and Biotechnology- A Presentation by Dr. Kalyan Kankanala - BananaIP
BananaIP Counsels, formerly Brain League IP Services, founded in 2004 at the Indian Institute of Management (IIM) Bangalore’s incubation center (NSRCEL), is recognized as an IP/Patent trailblazer in India. The firm’s mission is to help clients maximize business value from their Intellectual Property (IP)/Patents, and gain competitive advantage in the market place. In its evolution from Brain League, BananaIP carries forward the firm’s core values – Merger of Technology,Management and Law, Swift Adaptation to changes in competitive environment, and business driven approach to Intellectual Property (IP)/Patent Services.
Contact Us for Intellectual Property Services
BananaIP Counsels
Regd Office
No.40,3rd Main Road,JC Industrial Estate,
Kanakapura Road,Bangalore – 560 062.
Email: contact@bananaip.com
Telephone: +91-80-26860414 /24/34
Brief Profiles of 50 Bio-entrepreneurs of India along with their company information. Biotechnology in India is in nascent stage. India has around 800 biotech companies out of which only 50 are presented here. They represent all the waves of biotech growth in India.
This is part of the MaRS BioEntrepreneurship series.
Speaker: Lynne Zydowsky, Ph.D., Managing Principal Zydowsky Consultants
* Explore the development of regulated drugs and devices
* Understand where and how value is generated in the pharmaceuticals industry
* Appreciate the interplay between science and business in a biotech company
To download a copy of the audio for this presentation, please go to:
http://www.marsdd.com/bioent/oct16
For the event blog and Q+A, please see:
http://blog.marsdd.com/2006/10/17/bringing-together-art-and-science/
This presentation on the biotechnology sector details the initiatives, infrastructure and policies developed by the government to promote growth of the sector and also highlight the current business opportunities present in this sector.
Bharat Biotech’s research stems from the need to innovate and the necessity to address public health requirements of the developing nations, while adhering to IPR. Our business model is to support the advancement of technologies through strong collaborative research, and simultaneously support the establishment of strong innovative technology platforms for intellectual property reputed driven enterprise R&D.
Patent specification is a document through which an inventor discloses the details of his invention in exchange for the exclusive rights awarded by the government. From a broader perspective, the government expects a patent specification to disclose the invention details so that any person from the public (after the patent expires) can make and/or practice the invention thereby meeting the objective of the Patent law.
Contact Us for Intellectual Property Services
BananaIP Counsels
Regd Office
No.40,3rd Main Road,JC Industrial Estate,
Kanakapura Road,Bangalore – 560 062.
Email: contact@bananaip.com
Telephone: +91-80-26860414/24/34
ICICI Videocon loan case - NIFTEM MBA ActivitySiddartha B
Presentation gives the complete timeline of ICICI- Videocon Loan Case study. What happened to Rs 3,250 cr ?? What all happened from last 10 years?? Why Chanda Kochhar have pay back Rs 9.5 Cr Bonus from ICICI?
Creating or discovering a new life form by the use of genetic engineering sounds interesting.. but is it actually possible to patent life forms?
Watch out to know.
The Government of India, through an array of programs and initiatives, offers funding for technology development, from early-stage development to full-scale commercialization to prioritize innovative R&D and promote indigenous technology development. A number of national agencies i.e. Department of Biotechnology (DBT), Department of Science and Technology (DST), Department of Scientific & Industrial Research (DSIR), Council of Scientific & Industrial Research (CSIR), Ministry of Micro Small Medium Enterprises (MSME), National Research Development Corporation (NRDC), Defence Research & Development Organization (DRDO), Technology Information, Forecasting and Assessment Council (TIFAC), etc. have been supporting biotech companies as well as academia in various areas of biotechnology with a view to facilitate accelerated technology development.
Several international India-specific Grand Challenges i.e. Wellcome Trust, Bill & Melinda Gates Foundation, Grand Challenges Canada, Millenium Alliance and bilateral/multi-lateral programmes with other countries also support innovative technology development in India.
This is part of the MaRS BioEntrepreneurship series.
Speaker: Lynne Zydowsky, Ph.D., Managing Principal Zydowsky Consultants
* Explore the development of regulated drugs and devices
* Understand where and how value is generated in the pharmaceuticals industry
* Appreciate the interplay between science and business in a biotech company
To download a copy of the audio for this presentation, please go to:
http://www.marsdd.com/bioent/oct16
For the event blog and Q+A, please see:
http://blog.marsdd.com/2006/10/17/bringing-together-art-and-science/
This presentation on the biotechnology sector details the initiatives, infrastructure and policies developed by the government to promote growth of the sector and also highlight the current business opportunities present in this sector.
Bharat Biotech’s research stems from the need to innovate and the necessity to address public health requirements of the developing nations, while adhering to IPR. Our business model is to support the advancement of technologies through strong collaborative research, and simultaneously support the establishment of strong innovative technology platforms for intellectual property reputed driven enterprise R&D.
Patent specification is a document through which an inventor discloses the details of his invention in exchange for the exclusive rights awarded by the government. From a broader perspective, the government expects a patent specification to disclose the invention details so that any person from the public (after the patent expires) can make and/or practice the invention thereby meeting the objective of the Patent law.
Contact Us for Intellectual Property Services
BananaIP Counsels
Regd Office
No.40,3rd Main Road,JC Industrial Estate,
Kanakapura Road,Bangalore – 560 062.
Email: contact@bananaip.com
Telephone: +91-80-26860414/24/34
ICICI Videocon loan case - NIFTEM MBA ActivitySiddartha B
Presentation gives the complete timeline of ICICI- Videocon Loan Case study. What happened to Rs 3,250 cr ?? What all happened from last 10 years?? Why Chanda Kochhar have pay back Rs 9.5 Cr Bonus from ICICI?
Creating or discovering a new life form by the use of genetic engineering sounds interesting.. but is it actually possible to patent life forms?
Watch out to know.
The Government of India, through an array of programs and initiatives, offers funding for technology development, from early-stage development to full-scale commercialization to prioritize innovative R&D and promote indigenous technology development. A number of national agencies i.e. Department of Biotechnology (DBT), Department of Science and Technology (DST), Department of Scientific & Industrial Research (DSIR), Council of Scientific & Industrial Research (CSIR), Ministry of Micro Small Medium Enterprises (MSME), National Research Development Corporation (NRDC), Defence Research & Development Organization (DRDO), Technology Information, Forecasting and Assessment Council (TIFAC), etc. have been supporting biotech companies as well as academia in various areas of biotechnology with a view to facilitate accelerated technology development.
Several international India-specific Grand Challenges i.e. Wellcome Trust, Bill & Melinda Gates Foundation, Grand Challenges Canada, Millenium Alliance and bilateral/multi-lateral programmes with other countries also support innovative technology development in India.
Hi all, with the rigorous secondary research for almost one month helped me to understand basic things about biosimilars and made me do this presentation. Hope u will appreciate it while going through it. thanks.
If anyone in need of this presentation, pls.put ur emial ID in comment box. will be sharing. and please share your thoughts about the presentation. i will be more thankful.
3. Indian Biotech Products & Services: The Indian Biotech business stands at US$150 m today... … and is expected to be $ 750 m by 2005 and $1500 m by 2007… Bio-forecast #3 $ 150 $ 100 $ 150 $ 350 $1500m $750m $150m 2002 2005 2007 R&D Products & Services Ag Biotech Industrial Biotech Medical Biotech
4. Achievements ~ 50 Biotech PCT Patents have been filed in India ~ 20 r-DNA product clinical trials are on-going in India ~ 10 r-DNA products have been approved in India There are 6 r-DNA products being manufactured in India (Hep B, Interferon, GCSF, EPO, SK, BT cotton) There are 6 companies manufacturing recombinant vaccines There are 2 companies that will manufacture r-Human Insulin There are 2 companies developing Monoclonal Antibodies There are ~25 companies marketing Biotech products #4
5. New Delhi Pune Chennai Bangalore Hyderabad CCMB BHARAT BIOTECH SHANTHA BIOTECH DRL BIOLOGICAL E KNOWLEDGE PARK S-P BIOTECH PARK TCS ANNA UNIVERSITY MADURAI KAMARAJ UNIVERSITY SPIC PUNE UNIVERSITY ALFA LAVAL PRAJ INDUSTRIES SERUM INSTITUTE WOCKHARDT MIDC BIOTECH PARK IISC NCBS JNCASR IBAB ASTRA ZENENCA AURIGENE AVESTHAGEN BANGALORE GENEI BIOCON, SYNGENE GANGAGEN JUBILANT BIOSYS METAHELIX SARTORIUS STRAND GENOMICS BIOTECH PARK CROs: CLINIGENE, CLINITEC, LOTUS LABS DBT NII CBT DABUR GENOMED PANACEA BIOTECH JUBILANT Bio-clusters #5
15. India’s well developed fermentation and purification skills are being leveraged to a globally competitive bioprocessing platform... Bio-Processes in India #15 Biocon Shantha Biotech Serum Institute Shantha Biotech Bharat Biotech Wockhardt Panacea Biotech Dr. Reddy’s VACCINES RECOMBINANT THERAPEUTICS MONOCLONAL ANTIBODIES Biocon Wockhardt Dr. Reddy’s Shantha Biotech Bharat Biotech Hep B, Combi-vaccines Rabies, Leprosy Human Insulin, EPO, GCSF, SK, HGH, Interferon 2B Enti-EGF & others
16.
17.
18.
19. India is fast emerging as the hotbed of clinical research. One new CRO is being created every month... #19 CLINICAL DEVELOPMENT Siro Clinpharm Clinigene Quintiles Synchron Pfizer Clintec Covance Eli Lilly Novartis AstraZeneca Quintiles GSK Pfizer Novartis Eli Lilly DiagnoSearch Clinworld Infotech NEW DRUG TESTING BIO STUDIES BIOMETRICS/ DATA MANAGEMENT SITE MANAGEMENT Lambda Clinigene Lotus Labs Vimta Labs Apothecaries Synchron Wellquest Neemans
20. ``India is an attractive destination for clinical trials due to speed of patient enrollment and the quality of investigators.” Pawel Dyras V.P. Clintec "We have 17 large and small clinical trials in Phase II & III ongoing in India. ” Rajiv Gulati, Eli Lilly, India “ Folks at Biocon’s Syngene were certainly as fast as folks elsewhere, had a higher success rate and were almost an order of magnitude less expensive.” Peter Cohan, V.P. Discovery, SYMY “ It was the availability of high quality scientific talent and not the lower operational costs that led us to invest in a $40 million R&D centre at Bangalore.” Sir Tom McKillop, CEO AstraZeneca #20 Quotes